Vesale Pharmaceutica SA
2.8 FTEVesale Pharmaceutica reported total assets of €4.02m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026), with 2.8 full-time equivalents.
By total assets for 2025, Vesale Pharmaceutica ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Vesale Pharmaceutica shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets -26 % Headcount (avg FTE) -54 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Vesale Pharmaceutica's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Vesale Pharmaceutica's financial analysis
- Solvency77.1%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Vesale Pharmaceutica
Vesale Pharmaceutica's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0452.282.591
- VAT number
- BE0452282591
- Peppol
- Registered · 0208:0452282591 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Mar 1994
- Registered office
- 5032 Gembloux
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Vesale Pharmaceutica (SA) has been based in Gembloux since 1994, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 362,888 € and equity of €3.10m; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 77.1%, above the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Vesale Pharmaceutica
Companies in the same business, of comparable size and area, outside its group.
- Pannoc Chemie Manufacture of pharmaceutical preparations Olen · balance sheet €2.32m
- AIP Medical Manufacture of pharmaceutical preparations Olne · balance sheet €1.64m
- Fortilab Manufacture of pharmaceutical preparations Etterbeek · balance sheet €1.39m
- Cogezaf Wholesale of pharmaceutical and medical goods Gembloux · balance sheet €6.72m
- Unit Communication - CBF Médical Wholesale of pharmaceutical and medical goods Gembloux · balance sheet 764,164 €
- Lupumed Wholesale of pharmaceutical and medical goods Ghent · balance sheet €2.08m
- Fagron Belgium Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €7.86m
- Actifar Wholesale of perfume and cosmetics Mont-Saint-Guibert · balance sheet €3.08m
Frequently asked questions about Vesale Pharmaceutica
What is the revenue of Vesale Pharmaceutica?
Vesale Pharmaceutica files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Vesale Pharmaceutica?
In Belgium, the VAT number is the company number prefixed with BE: BE0452282591 for Vesale Pharmaceutica, if the company is VAT-registered. Its company number (CBE) is 0452.282.591.
Where is the registered office of Vesale Pharmaceutica?
According to the CBE register, the registered office of Vesale Pharmaceutica is in 5032 Gembloux.
What is the equity of Vesale Pharmaceutica?
At the close of the 2025 financial year, the equity of Vesale Pharmaceutica amounts to 3,104,110 €, a solvency of 77.1% of total assets.
How many people work at Vesale Pharmaceutica?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Vesale Pharmaceutica?
The register lists 4 active mandates at Vesale Pharmaceutica. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Vesale Pharmaceutica within its sector?
By total assets for 2025, Vesale Pharmaceutica ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Vesale Pharmaceutica
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →